Eisai and Biogen Launch Weekly Subcutaneous LEQEMBI IQLIK for Early Alzheimer’s in the U.S.

Eisai Co., Ltd. and Biogen Inc., announced that once weekly lecanemab-irmb subcutaneous injection (brand name: LEQEMBI IQLIK®) is now available in th...

August 26, 2026 | Wednesday | News
Japan Grants Orphan Drug Designation to Alkeus’ Gildeuretinol for Stargardt Disease

Alkeus Pharmaceuticals, Inc., a biopharmaceutical company dedicated to preserving the sight of individuals impacted by retinal diseases, announced that t...

August 26, 2026 | Wednesday | News
Leads Biolabs Advances Opamtistomig into Expansion Phase in First-Line Esophageal Cancer Trial

Nanjing Leads Biolabs Co., Ltd. (“Leads Biolabs” or the “Company,”  announced that Opamtistomig (LBL-024), the Company&rsquo...

August 26, 2026 | Wednesday | News
Quotient Sciences on How AI Is Reshaping the CDMO–Sponsor Relationship

    As AI and digital technologies increasingly influence pharmaceutical development, CDMOs are taking on a broader role in helping sponsors im...

August 25, 2026 | Tuesday | Interaction
Ipsen Completes Acquisition of Kartos Therapeutics, Adding Phase III Myelofibrosis Drug Candidate

Ipsen announced it has completed the acquisition of Kartos Therapeutics, a clinical-stage biopharmaceutical company adding late-stage MDM2 inhibitor navt...

August 24, 2026 | Monday | News
Orum Therapeutics Wins FDA Clearance for ORM-1153 AML Degrader-Antibody Conjugate

Orum Therapeutics(“Orum” or the “Company”), a biotechnology company pioneering the field of degrader-antibody conjugates (DACs), ...

August 24, 2026 | Monday | News
ACTG Opens STAIR-HIV Trial to Evaluate Alendronate as an HIV Latency-Reversing Agent

ACTG, a global clinical trials network focused on HIV and other infectious diseases, announced the opening of STAIR-HIV (Small Trial of Alendronate Impac...

August 21, 2026 | Friday | News
Ultragenyx Wins FDA Accelerated Approval for GENGLYCOS in GSDIa

GENGLYCOS is the first gene therapy approval, and fifth FDA approval overall, for the company Approval provides a long-awaited first-ever option to redu...

August 21, 2026 | Friday | News
Nanochon Receives Panama Approval to Begin First-in-Human Chondrograft Knee Study

Nanochon, a medical device company developing Chondrograft, a novel patented implant for the treatment of articular cartilage defects of the knee, announ...

August 17, 2026 | Monday | News
Aurisco Pharmaceutical Passes USFDA Inspection as First Generic Oligonucleotide API Manufacturer

Aurisco Pharmaceutical, a leading global Oligonucleotide and Peptide (TIDES) manufacturer, announced that its site in Yangzhou, China has passed the USFDA ...

August 17, 2026 | Monday | News
Aizen Therapeutics Enters Multi-Program Collaboration to Develop AI-Designed Oral Peptides

Aizen Therapeutics, an AI-native biotechnology company focused on building oral biologics, announced a multi-program collaboration with a San Diego-based...

August 17, 2026 | Monday | News
Building Biotech Development Strategies for an Uncertain Future

  Drug development is inherently uncertain, with scientific discoveries, manufacturing challenges, regulatory expectations and commercial priorities ...

August 14, 2026 | Friday | Expert Opinion
Building the Future of Pharma Marketing: Leadership, Flexibility and Talent in a Changing Industry

Pharmaceutical marketing is undergoing a significant transformation as companies balance regulatory complexity, digital disruption, evolving workforce ex...

August 03, 2026 | Monday | Interaction
Reading the Room: The Hidden Leadership Skill Shaping Biopharma Decisions

In biopharma, critical decisions are often shaped by more than clinical data, regulatory insights, or operational metrics. The most important signals m...

August 03, 2026 | Monday | News

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2026 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close